Canadian Liver Meeting 2021

10 $

+ Include: 42 videos, size: 15.9 GB

+ Target Audience: hepatologist

Description

+ Include: 42 videos, size: 15.9 GB

+ Target Audience: hepatologist

+ Sample video: contact me for sample video

+ Information:

The Canadian Liver Meeting to be delivered virtually on May 2 – 5, 2021, is a collaborative effort of the CASL, the AASLD, the CanHepC, and the CAHN. The meeting program offers a forum for presentation and discussion of basic science, translational and clinical aspects of liver disease. This is a unique opportunity to exchange ideas, promote collaboration and foster knowledge translation among Canadian researchers, healthcare practitioners, and community-based groups with interest in Hepatology.

Due to the COVID-19 pandemic, the 4th annual Canadian Liver Meeting (CLM) was delivered virtually for the first time on May 2-5, 2021. The CLM theme, ‘Minimizing disparity on the Path to Viral Hepatitis Elimination’, was a collaboration between the Canadian Association of the Study of the Liver (CASL), the Canadian Network on Hepatitis C (CanHepC) and the Canadian Association of Hepatology Nurses (CAHN).  For the first time, this year’s meeting collaborated with the American Association of the Study of the Liver (AASLD) for the inaugural North American Viral Hepatitis Elimination Summit, a two day symposium within the CLM.

There were 625 registrants from around the world, 50 of those being active CAHN members. CAHN’s program was well attended with 120-170 people per session.  We had over 7 hours of presentations, 17 presenters which included, which included, two hepatologists, a dietitian, and fourteen nurses. The overall satisfaction of the CAHN program was 4.5/5. The most attended talk was Nurse Led Models of Care and Nursing Strategies to Reach 2030 Elimination Goal. The agenda was developed primarily from topic suggestions by attendees at the CLM and CAHNference 2020, directly reflecting what our membership was asking for. It included nurse led models of care, case studies, and updates on fatty liver and autoimmune liver diseases. The program topics ranged from diagnosis and management of various liver diseases to our final session on progression, diagnosis, and management of end stage liver disease. We had our first Nursing Debate – virtual vs. in person care – along with many first time CAHN presenters. It was exciting to hear the amazing work our CAHN nurses are doing across the country, giving us so many things to learn from, share, and adapt in our own work environments. Thank you to all our presenters, who so generously share their experiences and knowledge with us.

The meeting platform worked very well, with multiple steams of talks going on at the same time, ability to chat with attendees, and sponsor ‘virtual booths’ we could visit. Don’t forget you can go back to the platform and view the sessions again.

We are already busy planning our upcoming CAHNference 2021 and the evaluations collected at the end of the CLM are being used to inform this agenda. If there are any topics you wish covered or are interested in presenting

 

+ Topics:

Day 1 – Conference Opening & Plenary Progress toward WHO Interim Targets for Hepatitis Elimination National Elimination Check-up.mp4
Day 1 – Conference Opening & Plenary Progress toward WHO Interim Targets for Hepatitis Elimination National Elimination Check-up_2.mp4
Day 2 – CAHN Welcome & PSCPBC.mp4
Day 2 – Challenges Facing Newcomers Immigrants Migrants Refugees – HBV (& HCV).mp4
Day 2 – Elimination of Viral Hepatitis in Children.mp4
Day 2 – Fatty Liver.mp4
Day 2 – Lived Experience Panel Eliminating Stigma to Eliminate Viral Hepatitis The Perspectives of People with Lived Experience.mp4
Day 2 – Meet the Expert – Wilson’s Disease (This education session is an unaccredited learning activity, with content developed.mp4
Day 2 – Nursing Strategies To Reach the 2030 Elimination Goal.mp4
Day 2 – Oral Presentations I.mp4
Day 2 – Plenary Panel on Elimination How Disparities Affect the Viral Hepatitis Elimination Agenda.mp4
Day 2 – Progress Toward an HCV Vaccine.mp4
Day 2 – Seizing Opportunities Prevention of Late Diagnosis.mp4
Day 2 – Sponsored Symposium Exploring Touchpoints in HCV Care An Interactive Debate (This education session is an unaccredited l.mp4
Day 2 – Structural Racism – Impact on Burden and Equity to Care.mp4
Day 2 – The Great Debate – Virtual vs In person Care – Which is Better.mp4
Day 2 – Viral Hepatitis & PWID.mp4
Day 3 – A Case Based Roundtable Discussion The MDT Approach to HCC Management (This is an unaccredited other learning activity s.mp4
Day 3 – Basic Science and Translational Research Novel Approaches to Targeting Chronic Liver Disease and Liver Injury.mp4
Day 3 – CanHepC Awards Ceremony.mp4
Day 3 – Case studies in Liver disease.mp4
Day 3 – Elimination Summit Next Steps.mp4
Day 3 – HDV Cure.mp4
Day 3 – How COVID has Impacted Viral Hepatitis and the Elimination Agenda (This session was co-developed with Gilead and was pla.mp4
Day 3 – Nurse-Led Models of Care.mp4
Day 3 – Opportunities from COVID to Enhance Elimination.mp4
Day 3 – Oral Presentations II.mp4
Day 3 – Special Topics in Hepatology.mp4
Day 3 – Strategies for HBV Cure & HCC After Cure of HCV or Suppression of HBV.mp4
Day 4 – Addressing Disparities and Controversies in End-Stage Liver Diseases.mp4
Day 4 – Approach to Special Populations and Liver Disease.mp4
Day 4 – Ask the Expert Shifting Goalposts Risk-Based Treatment of PBC (This is an unaccredited other learning activity supported.mp4
Day 4 – CASL-CLF Sass-Kortsak Award Presentation & Lecture.mp4
Day 4 – CLF-CASL Gold Medal Award Presentation & Lecture & CASL Award Ceremony & Closing Remarks.mp4
Day 4 – End Stage Liver Disease Management & CAHN Closing Remarks.mp4
Day 4 – Meet the Expert (This education session is an unaccredited learning activity, with content developed by the speaker, and.mp4
Day 4 – NAFLD – New Developments.mp4
Day 4 – Oral Presentation III.mp4
Day 4 – Oral Presentations IV.mp4
Day 4 – Quality Metrics for Cirrhosis Care (This session was co-developed with Lupin and was planned to achieve scientific integ.mp4
Day 4 – Translational Research in HCC and Liver Disease.mp4
Day 4 – Transplant Controversies and New Developments.mp4

Reviews

There are no reviews yet.

Be the first to review “Canadian Liver Meeting 2021”

Your email address will not be published. Required fields are marked *